Metabolic study of selective androgen receptor modulator LY2452473 in thoroughbred horses for doping control
Rapid Communications in Mass Spectrometry · 2023
DOI: 10.1002/rcm.9491 ↗Kurz gefasst
Fachartikel in der Zeitschrift Rapid Communications in Mass Spectrometry, 2023. Verfasst von Tajudheen K Karatt und 8 weiteren Autor:innen. Beteiligte Einrichtung: Equine Forensic Unit, Central Veterinary Research Laboratory, Dubai, United Arab Emirates. Hauptthemen laut MEDLINE: Doping in Sports. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 34 Literaturangaben.
Abstract (Originalsprache)
Rationale
Since 2010, there has been an increasing number of adverse analytical findings related to selective androgen receptor modulators (SARMs) in competitive sports. It emphasizes the importance of comprehensive doping control analytical procedures that are capable of detecting SARM misuse.
Methods
In this study, it is described how LY2452473, a SARM, was metabolized in thoroughbred horses after a single‐dose oral administration and in vitro with equine liver microsome preparations. An investigation of the metabolism of LY2452473 in horses' urine, plasma, and hair matrices was carried out during the study. The plausible structures of the detected metabolites were postulated using high‐performance liquid chromatography‐high resolution mass spectrometry.
Results
Under the experimental conditions 15 metabolites (12 phase I and three conjugates of phase I) were detected ( M1 – M15 ). The major phase I metabolites identified were formed by hydroxylation. Side‐chain dissociated and methylated metabolites were also detected. In phase II, the glucuronic acid and sulfonic acid conjugates of hydroxy LY2452473 were detected as the major metabolites. In vitro analysis has confirmed the presence of all metabolites found in vivo except for the methylated analogs M11 and M12 . A peak concentration of LY2452473 (0.5 pg/mg) in proximal hair segments was achieved 4 weeks after administration, according to hair analysis.
Conclusions
Data obtained will aid in identifying LY2452473 and related substances faster. Furthermore, the results will assist in checking for the illegal use of these substances in competitive sports.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Equine Forensic Unit, Central Veterinary Research Laboratory, Dubai, United Arab Emirates.
- Post Graduate and Research Department of Chemistry, Jamal Mohamed College (Affiliated to Bharathidasan University), Tiruchirappalli, Tamil Nadu, India.
- Department of Chemistry, College of Science, United Arab Emirates University, Al Ain, United Arab Emirates.
ORCID-Profile: Abdul Khader Karakka Kal
Zitieren
APA
Karatt, T. K., Sathiq, M. A., Laya, S., Karakka Kal, A. K., Subhahar, M. B., M P, M. A., Philip, M., Graiban, F. M., & Caveney, M. R. (2023). Metabolic study of selective androgen receptor modulator LY2452473 in thoroughbred horses for doping control. Rapid Communications in Mass Spectrometry. https://doi.org/10.1002/rcm.9491
Vancouver
Karatt TK, Sathiq MA, Laya S, Karakka Kal AK, Subhahar MB, M P MA, et al. Metabolic study of selective androgen receptor modulator LY2452473 in thoroughbred horses for doping control. Rapid Communications in Mass Spectrometry. 2023. doi:10.1002/rcm.9491
BibTeX
@article{Karatt2023,
author = {Karatt, Tajudheen K and Sathiq, M Anwar and Laya, Saraswathy and Karakka Kal, Abdul Khader and Subhahar, Michael Benedict and M P, Muhammed Ajeebsanu and Philip, Moses and Graiban, Fatma Mohammed and Caveney, Marina Rodriguez},
title = {Metabolic study of selective androgen receptor modulator LY2452473 in thoroughbred horses for doping control},
journal = {Rapid Communications in Mass Spectrometry},
year = {2023},
doi = {10.1002/rcm.9491}
}
EUVIMED